[Federal Register Volume 67, Number 147 (Wednesday, July 31, 2002)]
[Notices]
[Pages 49705-49706]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-19264]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., a amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Diabetes Complications.
    Date: August 1, 2002.
    Time: 10 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: NIH, Rockledge 2, Bethesda, MD 20892, (Telephone Conference 
Call).
    Contact Person: Ann A. Jerkins, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6154, MSC 7892, Bethesda, MD 20892, 
(301) 435-4514.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and funding 
cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Apoptosis and Carcinogenesis.
    Date: August 2, 2002.
    Time: 11:30 a.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: NIH, Rockledge 2, Bethesda, MD 20892, (Telephone Conference 
Call).
    Contact Person: Sharon K. Pulfer, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4140, MSC 7804, Bethesda, MD 20892, 
(301) 435-1767.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and funding 
cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, ZRG1 ET-2 (05) HPV.
    Date: August 5, 2002.
    Time: 1 p.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: NIH, Rockledge 2, Bethesda, MD 20892, (Telephone Conference 
Call).
    Contact Person: Marcia Litwack, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4150, MSC 7804, Bethesda, MD 20892, 
(301) 435-1719.

    This notice is being published less than 15 days prior to the 
meeting due

[[Page 49706]]

to the timing limitations imposed by the review and funding cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Immunologic Mechanisms of PDT Therapy.
    Date: August 5, 2002.
    Time: 2 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: NIH, Rockledge 2, Bethesda, MD 20892, (Telephone Conference 
Call).
    Contact Person: Sharon K. Pulfer, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4140, MSC 7804, Bethesda, MD 20892, 
(301) 435-1767.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and funding 
cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, ZRG1 GRM 08.
    Date: August 6, 2002.
    Time: 9:30 a.m. to 10 a.m.
    Agenda: To review and evaluate grant applications.
    Place: NIH, Rockledge 2, Bethesda, MD 20892 (Telephone Conference 
Call).
    Contact Person: Jo Pelham, BA, Scientific Review Administrator, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4102, MSC 7814, Bethesda, MD 20892, (301) 435-
1786.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and funding 
cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Experimental Therapeutics.
    Date: August 6, 2002.
    Time: 11:30 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: NIH, Rockledge 2, Bethesda, MD 20892 (Telephone Conference 
Call).
    Contact Person: Sharon K. Pulfer, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4140, MSC 7804, Bethesda, MD 20892, 
(301) 435-1767.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and funding 
cycle.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Placebo Effect RFA.
    Date: August 7, 2002.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn, 8120 Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: J. Scott Osborne, PhD, Scientific Review 
Administrator, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4114, MSC 7816, Bethesda, MD 20892, 
(301) 435-1782.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and funding 
cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine, 93.306; 93.333, Clinical Research, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: July 24, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-19264 Filed 7-30-02; 8:45 am]
BILLING CODE 4140-01-M